Thomas J. Appio
2019
In 2019, Thomas J. Appio earned a total compensation of $4M as President Co, Head Bausch + Lomb/International at Valeant Pharmaceuticals International, a 10% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $892,800 |
---|---|
Option Awards | $525,050 |
Salary | $768,942 |
Stock Awards | $1,343,982 |
Other | $427,227 |
Total | $3,958,001 |
Appio received $1.3M in stock awards, accounting for 34% of the total pay in 2019.
Appio also received $892.8K in non-equity incentive plan, $525.1K in option awards, $768.9K in salary and $427.2K in other compensation.
Rankings
In 2019, Thomas J. Appio's compensation ranked 3,025th out of 13,971 executives tracked by ExecPay. In other words, Appio earned more than 78.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,025 out of 13,971 | 78th |
Division Manufacturing | 1,095 out of 5,701 | 81st |
Major group Chemicals And Allied Products | 364 out of 2,200 | 84th |
Industry group Drugs | 298 out of 1,886 | 84th |
Industry Pharmaceutical Preparations | 219 out of 1,398 | 84th |
Source: SEC filing on May 2, 2022.
Appio's colleagues
We found three more compensation records of executives who worked with Thomas J. Appio at Valeant Pharmaceuticals International in 2019.